Navigation Links
Women With Atypia Nearly Eight Times More Likely to Develop Breast Cancer

Washington, June 30 (ANI): A new study has found that women with at least three sites of cellular atypia in breast tissue are nearly eight times more likely than average women to develop breast cancer.

Several earlier studies have shown that atypical hyperplasia (also called atypia) in breast tissue is a major risk factor for breast cancer. Women who have a breast biopsy and are diagnosed with atypia are considered at high risk.

Many are adviced to consider defensive medications such as tamoxifen or other risk-reducing approaches. However, questions remained from previous research on whether a positive family history further increases risk in women with atypia and for how long the increased risk in women with atypia lasts.

The most commonly used tool for risk prediction in women with atypia is the Gail model, which may predict inaccurately because our study shows that family history does not change risk significantly in women with atypia.

Our findings indicate that women with atypia have a higher absolute risk for breast cancer than previously estimated. This risk is 25 percent over 25 years and is much higher in women with multiple areas of atypia and calcification, says Amy Degnim, M.D., a Mayo Clinic surgeon and study author.

The Gail model predicts risk by using age at commencement of menses, age at birth of first child, number of previous breast biopsies, existence of atypia, and number of close relatives with breast cancer.

While the Mayo Clinic study found that family history did not further augment risk, age at diagnosis of atypia did have an effect on risk, with younger women (under age 45) more than twice as likely to develop breast cancer compared to women diagnosed with atypia after 55.

The number of areas of atypical hyperplasia was noteworthy as well. With one area of atypia, breast cancer risk was 2.3-fold compar ed to the general population; this risk more than doubled when two sites were found and augmented to nearly eightfold as sites increased to three or more.

The group of women with the highest risk had three or more areas of atypia and calcification -- with a 10.4-fold risk over the general population.

With the ability to stratify the risk of breast cancer in women with atypia, we can have more informed discussions with our patients regarding their personal risk. This will help us to have individualized discussions regarding how aggressively to pursue risk-reduction treatments, says Dr. Degnim.

These findings resulted from reassessing the records of 331 women with atypia identified within the Mayo group of 9,376 women who had benign breast biopsies surgically obtained between 1967 and 1991.

More than half (55.9 percent) of the women were over age 55 when diagnosed with atypia, and 42.9 percent had a family history of breast cancer. The majority (68.6 percent) of women showed calcification in the biopsy tissue, and 40 percent had multiple sites of atypical hyperplasia.

The current study contributes to Mayos up-and-coming model that seeks to identify every womans risk more accurately and to tailor screening and risk-reduction measures to women depending on their individual risks.


'"/>




Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... ... All-Star Insurance, a family managed agency that offers insurance management assistance and personal ... of a new charity drive to benefit women in the area diagnosed with breast ... estimated 252, 710 new cases of invasive or high risk breast cancer will be ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... 2017 , ... Despite its pervasiveness, many physicians are unfamiliar with how best ... with clinical practice. Now, however, a timely review has been published in the ... etiology of NeuP and educating preclinical scientists on its diagnosis and choice of treatment. ...
(Date:6/22/2017)... ... June 23, 2017 , ... Rise Against Hunger ... June 21, 2017, at the Emeryville Center of Community Life. More than 374 ... world. , Rise Against Hunger (formerly Stop Hunger Now) meal packaging events are ...
(Date:6/20/2017)... , ... June 20, 2017 , ... After months of negotiations, FaceCradle USA is proud ... on Wednesday, June 21. , “Introducing our product on QVC is something we all ... promote our travel pillow to more than 90 million homes in the United States,” said ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... Iowa , June 6, 2017  Diplomat Specialty Infusion Group, ... sterile compounding environment to its Iowa location. ... Urbandale now features an ISO 7 cleanroom—the standard ... controlled environment with a low level of pollutants. ... more IV nutrition consumers and better serve our Iowa ...
(Date:6/1/2017)... 1, 2017 Nutriceutical Holdings (NH), parent company ... (VRS), and KD Pharma Group have decided to join ... KD Pharma Group. KD Pharma Group will become the ... acquire the entire company. "We believe we ... committed to growing the NH companies by providing us ...
Breaking Medicine Technology: